Insider · CIK 0001528185

Torley Helen

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001528185

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-10-08	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−4,810 sh	$108.18	−$520K	782,970
2026-10-08	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−3,090 sh	$108.91	−$337K	779,880
2026-10-08	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−11.9K sh	$110.00	−$1.31M	767,980
2026-10-08	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−200 sh	$110.51	−$22.1K	767,780
2026-10-08	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	21,552
2026-10-07	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-10-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−8,600 sh	$111.03	−$955K	779,180
2026-10-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−10.3K sh	$111.84	−$1.15M	768,880
2026-10-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−900 sh	$112.78	−$102K	767,980
2026-10-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−200 sh	$113.69	−$22.7K	767,780
2026-10-07	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	41,552
2026-10-06	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-10-06	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−2,300 sh	$107.90	−$248K	785,480
2026-10-06	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−6,000 sh	$109.33	−$656K	779,480
2026-10-06	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−9,920 sh	$109.89	−$1.09M	769,560
2026-10-06	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−1,780 sh	$110.81	−$197K	767,780
2026-10-06	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	61,552
2026-09-11	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-09-11	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−15.5K sh	$107.15	−$1.66M	772,288
2026-09-11	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−4,508 sh	$107.55	−$485K	767,780
2026-09-11	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	81,552
2026-09-10	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-09-10	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−14.6K sh	$107.01	−$1.56M	773,192
2026-09-10	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−5,412 sh	$107.58	−$582K	767,780
2026-09-10	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	101,552
2026-09-09	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-09-09	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−13.3K sh	$107.22	−$1.43M	774,476
2026-09-09	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−6,596 sh	$107.82	−$711K	767,880
2026-09-09	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−100 sh	$108.67	−$10.9K	767,780
2026-09-09	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	121,552
2026-08-19	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-08-19	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−7,200 sh	$106.36	−$766K	780,580
2026-08-19	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−9,600 sh	$107.22	−$1.03M	770,980
2026-08-19	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−3,200 sh	$107.77	−$345K	767,780
2026-08-19	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	141,552
2026-08-18	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-08-18	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−5,703 sh	$103.08	−$588K	782,077
2026-08-18	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−4,897 sh	$104.11	−$510K	777,180
2026-08-18	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−9,400 sh	$104.87	−$986K	767,780
2026-08-18	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	161,552
2026-08-17	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+20K sh	$18.41	+$368K	787,780
2026-08-17	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−900 sh	$98.96	−$89.1K	786,880
2026-08-17	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−500 sh	$100.46	−$50.2K	786,380
2026-08-17	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−2,100 sh	$101.77	−$214K	784,280
2026-08-17	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−9,000 sh	$102.55	−$923K	775,280
2026-08-17	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−7,500 sh	$103.48	−$776K	767,780
2026-08-17	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−20K sh	$18.41	−$368K	181,552
2026-07-08	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+1,923 sh	$12.07	+$23.2K	769,703
2026-07-08	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−888 sh	$79.28	−$70.4K	768,815

Recent filings

Accepted (ET)
Oct 84
Torley Helen0001159036-26-000140
SEC(opens sec.gov)
Sep 114
Torley Helen0001159036-26-000119
SEC(opens sec.gov)

Companies

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130